☆ 4.5 Editorial Material

The selective VEGFR inhibitor PTK787/ZK 222584 represses the activities of VEGFR-negative bone marrow-derived mesenchymal stem cells

CANCER BIOLOGY & THERAPY (2009)

Get Full Text
Add to Collection

Journal

CANCER BIOLOGY & THERAPY
Volume 8, Issue 13, Pages 1249-1251

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/cbt.8.13.8996

Keywords

Mesenchymal stem cells; VEGFR inhibitor; PZK/ZK (Vatalanib); antitumor therapy; VEGF; PDGF

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.